Preclinical Comparison of the (64)Cu- and (68)Ga-Labeled GRPR-Targeted Compounds RM2 and AMTG, as Well as First-in-Humans [(68)Ga]Ga-AMTG PET/CT.
- DOI
- 10.2967/jnumed.123.265771
- Published
- 2023 Oct
- Container
- Journal of nuclear medicine : official publication, Society of Nuclear Medicine
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.2967/jnumed.123.265771,
title = {Preclinical Comparison of the (64)Cu- and (68)Ga-Labeled GRPR-Targeted Compounds RM2 and AMTG, as Well as First-in-Humans [(68)Ga]Ga-AMTG PET/CT.},
author = {Koller L and Joksch M and Schwarzenböck S and Kurth J and Heuschkel M and Holzleitner N and Beck R and von Amsberg G and Wester HJ and Krause BJ and Günther T},
year = {2023},
journal = {Journal of nuclear medicine : official publication, Society of Nuclear Medicine},
doi = {10.2967/jnumed.123.265771},
url = {https://doi.org/10.2967/jnumed.123.265771}
}RIS
TY - JOUR TI - Preclinical Comparison of the (64)Cu- and (68)Ga-Labeled GRPR-Targeted Compounds RM2 and AMTG, as Well as First-in-Humans [(68)Ga]Ga-AMTG PET/CT. AU - Koller L AU - Joksch M AU - Schwarzenböck S AU - Kurth J AU - Heuschkel M AU - Holzleitner N AU - Beck R AU - von Amsberg G AU - Wester HJ AU - Krause BJ AU - Günther T PY - 2023 JO - Journal of nuclear medicine : official publication, Society of Nuclear Medicine DO - 10.2967/jnumed.123.265771 UR - https://doi.org/10.2967/jnumed.123.265771 ER -
APA
L, K., M, J., S, S., J, K., M, H., N, H., R, B., G, V. A., HJ, W., BJ, K., & T, G. (2023). Preclinical Comparison of the (64)Cu- and (68)Ga-Labeled GRPR-Targeted Compounds RM2 and AMTG, as Well as First-in-Humans [(68)Ga]Ga-AMTG PET/CT.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. https://doi.org/10.2967/jnumed.123.265771
Source records
- pubmed · retrieved 2026-09-26T16:14:11.808Z